Hisao Nagoshi

928 total citations
38 papers, 520 citations indexed

About

Hisao Nagoshi is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hisao Nagoshi has authored 38 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Pathology and Forensic Medicine and 13 papers in Molecular Biology. Recurrent topics in Hisao Nagoshi's work include Lymphoma Diagnosis and Treatment (13 papers), Multiple Myeloma Research and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Hisao Nagoshi is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Multiple Myeloma Research and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Hisao Nagoshi collaborates with scholars based in Japan and Australia. Hisao Nagoshi's co-authors include Masafumi Taniwaki, Junya Kuroda, Shigeo Horiike, Tsutomu Kobayashi, Yuji Shimura, Yosuke Matsumoto, Mio Yamamoto‐Sugitani, Yoshiaki Chinen, Nana Sasaki and Miki Kiyota and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Hisao Nagoshi

35 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hisao Nagoshi Japan	12	299	149	146	136	118	38	520
Yoshiaki Chinen Japan	14	291 1.0×	170 1.1×	78 0.5×	143 1.1×	134 1.1×	49	513
Mio Yamamoto‐Sugitani Japan	10	219 0.7×	129 0.9×	95 0.7×	94 0.7×	91 0.8×	18	363
Bruno A. Cardoso Portugal	14	434 1.5×	250 1.7×	234 1.6×	230 1.7×	65 0.6×	25	858
Bertrand Montpellier France	6	209 0.7×	116 0.8×	163 1.1×	143 1.1×	144 1.2×	9	506
Christian Hurtz United States	10	246 0.8×	258 1.7×	151 1.0×	115 0.8×	47 0.4×	32	607
Richard Monni France	8	305 1.0×	244 1.6×	99 0.7×	200 1.5×	70 0.6×	8	603
Cathy Quelen France	14	395 1.3×	157 1.1×	60 0.4×	110 0.8×	83 0.7×	20	627
Garrett W. Rhyasen United States	8	288 1.0×	217 1.5×	205 1.4×	91 0.7×	28 0.2×	11	555
Alberto Rocci Italy	14	417 1.4×	373 2.5×	99 0.7×	170 1.3×	53 0.4×	32	661
Takuma Ishizaki Japan	11	193 0.6×	113 0.8×	88 0.6×	61 0.4×	32 0.3×	45	414

Countries citing papers authored by Hisao Nagoshi

Since Specialization

Citations

This map shows the geographic impact of Hisao Nagoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisao Nagoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisao Nagoshi more than expected).

Fields of papers citing papers by Hisao Nagoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisao Nagoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisao Nagoshi. The network helps show where Hisao Nagoshi may publish in the future.

Co-authorship network of co-authors of Hisao Nagoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Hisao Nagoshi. A scholar is included among the top collaborators of Hisao Nagoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisao Nagoshi. Hisao Nagoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagoshi, Hisao, et al.. (2020). Streptococcus gallolyticus ssp. pasteurianus bacteremia during chemotherapy-induced neutropenia in a patient with malignant lymphoma. Hiroshima University Acedemic Information Repository (Hiroshima University). 69(2). 47–50. 1 indexed citations

Matsumoto, Yosuke, Yoshiaki Chinen, Yuji Shimura, et al.. (2019). Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma. International Journal of Hematology. 111(1). 75–83. 3 indexed citations

Ide, Kentaro, Shinji Hashimoto, Hisao Nagoshi, et al.. (2019). Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report. Transplantation Proceedings. 52(2). 600–603. 1 indexed citations

Nagoshi, Hisao, Taku Tsukamoto, Yoshiaki Chinen, et al.. (2018). Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline. Cancer Genomics & Proteomics. 15(3). 213–223. 10 indexed citations

Tatsumi, Hiroshi, Hisao Nagoshi, Yoshiaki Chinen, et al.. (2017). Extranodal marginal zone lymphoma of the uterine cervix with concomitant copy number gains of the MALT1 and BCL2 genes: A case report. Oncology Letters. 13(5). 3641–3645. 2 indexed citations

Mizutani, Shinsuke, Junya Kuroda, Nana Sasaki, et al.. (2016). Quadruple Cancers of Non-producing Multiple Myeloma, Cholangiocellular Carcinoma, and Two Different Thyroid Cancers. Internal Medicine. 55(9). 1183–1186. 1 indexed citations

Tsukamoto, Taku, Miki Kiyota, Eri Kawata, et al.. (2016). Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era. International Journal of Hematology. 105(5). 658–667. 5 indexed citations

Okuda, Takashi, Tomohiko Taki, Kazuhiro Nishida, et al.. (2016). Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26. Oncology Letters. 13(1). 215–221. 7 indexed citations

Chinen, Yoshiaki, Junya Kuroda, Yuji Shimura, et al.. (2014). Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma. Cancer Research. 74(24). 7418–7429. 28 indexed citations

10.

Kuroda, Junya, Ayumi Kodama, Yoshiaki Chinen, et al.. (2014). NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia Research. 38(5). 619–624. 5 indexed citations

11.

Kobayashi, Satoru, Tomohiko Taki, Hisao Nagoshi, et al.. (2014). Identification of novel fusion genes with 28S ribosomal DNA in hematologic malignancies. International Journal of Oncology. 44(4). 1193–1198. 6 indexed citations

12.

Kuroda, Junya, Mio Yamamoto‐Sugitani, Sayori Wada, et al.. (2013). Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells. Leukemia Research. 38(1). 103–108. 14 indexed citations

13.

Kuroda, Junya, Hisao Nagoshi, Yuji Shimura, & Masafumi Taniwaki. (2013). Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma. Expert Review of Anticancer Therapy. 13(9). 1081–1088. 12 indexed citations

14.

Nagoshi, Hisao, Junya Kuroda, Tsutomu Kobayashi, et al.. (2013). Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis. International Journal of Hematology. 98(3). 366–374. 23 indexed citations

15.

Nagoshi, Hisao, Tomohiko Taki, Ichiro Hanamura, et al.. (2012). Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality. Cancer Research. 72(19). 4954–4962. 82 indexed citations

16.

Shimura, Yuji, Junya Kuroda, Masaki Ri, et al.. (2012). RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma. Molecular Cancer Therapeutics. 11(12). 2600–2609. 28 indexed citations

17.

Kiyota, Miki, Tsutomu Kobayashi, Shin‐ichi Fuchida, et al.. (2012). Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma. International Journal of Hematology. 95(5). 516–526. 10 indexed citations

18.

Sasaki, Nana, Junya Kuroda, Hisao Nagoshi, et al.. (2011). Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression. Experimental Hematology. 39(8). 817–828.e1. 26 indexed citations

19.

Yamamoto‐Sugitani, Mio, Junya Kuroda, Eishi Ashihara, et al.. (2011). Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia. Proceedings of the National Academy of Sciences. 108(42). 17468–17473. 77 indexed citations

20.

Kuroda, Junya, Hisao Nagoshi, Tsutomu Kobayashi, et al.. (2010). Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia. Molecular Cancer Research. 8(7). 994–1001. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact